{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T18:51:42Z","timestamp":1694631102022},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2004,10,1]],"date-time":"2004-10-01T00:00:00Z","timestamp":1096588800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2004,10,1]],"date-time":"2004-10-01T00:00:00Z","timestamp":1096588800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr. Treat. Options in Oncol."],"published-print":{"date-parts":[[2004,10]]},"DOI":"10.1007\/s11864-004-0032-4","type":"journal-article","created":{"date-parts":[[2007,6,28]],"date-time":"2007-06-28T08:40:14Z","timestamp":1183020014000},"page":"427-437","source":"Crossref","is-referenced-by-count":0,"title":["Regional therapy of liver metastases"],"prefix":"10.1007","volume":"5","author":[{"given":"Jonathan","family":"Whisenant","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alan","family":"Venook","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"32_CR1","first-page":"S22","volume":"46","author":"T Kato","year":"2003","unstructured":"Kato T, Yasui K, Hirai T, et al.: Therapeutic results for hepatic metastasis of colorectal cancer with special reference to effectiveness of hepatectomy: analysis of prognostic factors for 763 cases recorded at 18 institu-tions. Dis Colon Rectum 2003, 46:S22-S31.","journal-title":"Dis Colon Rectum"},{"key":"32_CR2","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1002\/jso.2930550108","volume":"55","author":"S Schneebaum","year":"1994","unstructured":"Schneebaum S, Walker MJ, Young D, et al.: The regional treatment of liver metastases from breast cancer. J Surg Oncol 1994, 55:26\u201331; discussion 32.","journal-title":"J Surg Oncol"},{"issue":"2","key":"32_CR3","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/S1051-0443(98)70262-3","volume":"9","author":"T Habbe","year":"1998","unstructured":"Habbe T, McCowan T, Goertzen T, et al.: Complications and technical limitations of hepatic arterial infusion catheter placement for chemotherapy. J Vasc Interv Radiol 1998, 9(2):233\u2013239.","journal-title":"J Vasc Interv Radiol"},{"key":"32_CR4","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1067\/msy.2003.37","volume":"133","author":"S Heinrich","year":"2003","unstructured":"Heinrich S, Petrowsky H, Schwinnen I, et al.: Technical complications of continuous intra-arterial chemother-apy with 5-fluorodeoxyuridine and 5-fluorouracil for colorectal liver metastases. Surgery 2003, 133:40\u201348.","journal-title":"Surgery"},{"key":"32_CR5","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1038\/bjc.1995.455","volume":"72","author":"C Fordy","year":"1995","unstructured":"Fordy C, Burke D, Earlam S, et al.: Treatment interrup-tions and complications with two continuous hepatic artery floxuridine infusion systems in colorectal liver metastases. Br J Cancer 1995, 72:1023\u20131025.","journal-title":"Br J Cancer"},{"issue":"4","key":"32_CR6","doi-asserted-by":"crossref","first-page":"459","DOI":"10.7326\/0003-4819-107-4-459","volume":"107","author":"N Kemeny","year":"1987","unstructured":"Kemeny N, Daly J, Reichman B, et al.: Intrahepatic or systemic infusion of fluorodeoxyuridine in patients with liver metastases from colorectal carcinoma. Ann Intern Med 1987, 107(4):459\u2013465.","journal-title":"Ann Intern Med"},{"key":"32_CR7","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1200\/JCO.1989.7.11.1646","volume":"7","author":"DC Hohn","year":"1989","unstructured":"Hohn DC, Stagg RJ, Friedman MA, et al.: A randomized trial of continuous intravenous versus intraarterial floxuridine in patients with colorectal cancer meta-static to the liver: The Northern Oncology Group Trial. J Clin Oncol 1989, 7:1646\u20131654.","journal-title":"J Clin Oncol"},{"key":"32_CR8","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1097\/00000658-198712000-00001","volume":"206","author":"AE Chang","year":"1987","unstructured":"Chang AE, Schneider PD, Sugarbaker PH, et al.: A pro-spective randomized trial of regional versus systemic continuous 5-fluorodeoxyuridine chemotherapy in the treatment of colorectal liver metastases. Ann Surg 1987, 206:685\u2013693.","journal-title":"Ann Surg"},{"key":"32_CR9","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1001\/archsurg.1990.01410200086013","volume":"125","author":"JK Martin","year":"1990","unstructured":"Martin JK Jr, O\u2019Connell MJ, Wieand HS, et al.: Intra-arte-rial floxuridine vs systemic fluorouracil for hepatic metastases from colorectal cancer. Arch Surg 1990, 125:1022\u20131027.","journal-title":"Arch Surg"},{"key":"32_CR10","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1200\/JCO.1993.11.5.822","volume":"11","author":"CA Campbell","year":"1993","unstructured":"Campbell CA, Burns RC, Sitzmann JV, et al.: Regional chemotherapy devices: effect of experience and anat-omy on complications. J Clin Oncol 1993, 11:822\u2013826.","journal-title":"J Clin Oncol"},{"key":"32_CR11","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1002\/1097-0142(19860201)57:3<465::AID-CNCR2820570311>3.0.CO;2-S","volume":"57","author":"DC Hohn","year":"1986","unstructured":"Hohn DC, Rayner AA, Exonomou JS, et al.: toxicities and complications of implanted pump hepatic arte-rial and intravenous floxuridine infusion. Cancer 1986, 57:465\u2013470.","journal-title":"Cancer"},{"key":"32_CR12","first-page":"928","volume":"114","author":"SA Curley","year":"1993","unstructured":"Curley SA, Chase JL, Roh MS, et al.: Technical consider-ations and complications associated with the place-ment of 180 implantable hepatic arterial infusion devices. Surgery 1993, 114:928\u2013935.","journal-title":"Surgery"},{"key":"32_CR13","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1002\/1097-0142(19920115)69:2<327::AID-CNCR2820690209>3.0.CO;2-U","volume":"69","author":"N Kemeny","year":"1992","unstructured":"Kemeny N, Seiter K, Niedzwiecki D, et al.: A random-ized trial of intrahepatic infusion of fluorodeoxyuri-dine with dexamethasone versus fluorodeoxyuridine alone in the treatment of metastatic colorectal cancer. Cancer 1992, 69:327\u2013334.","journal-title":"Cancer"},{"key":"32_CR14","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1002\/1097-0142(19940215)73:4<1134::AID-CNCR2820730403>3.0.CO;2-V","volume":"73","author":"N Kemeny","year":"1994","unstructured":"Kemeny N, Seiter K, Conti JA, et al.: Hepatic arterial floxuridine and leucovorin for unresectable liver metastases from colorectal carcinoma. Cancer 1994, 73:1134\u20131142.","journal-title":"Cancer"},{"key":"32_CR15","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1093\/jnci\/83.6.423","volume":"83","author":"RJ Stagg","year":"1991","unstructured":"Stagg RJ, Venook AP, Chase JL, et al.: Alternating hepatic intra-arterial floxuridine and fluorouracil: a less toxic regimen for treatment of liver metastases from col-orectal cancer. J Natl Cancer Inst 1991, 83:423\u2013428.","journal-title":"J Natl Cancer Inst"},{"key":"32_CR16","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.1200\/JCO.1994.12.11.2288","volume":"12","author":"N Kemeny","year":"1994","unstructured":"Kemeny N, Conti JA, Cohen A, et al.: Phase II study of hepatic arterial floxuridine, leucovorin, and dexam-ethasone for unresectable liver metastases from col-orectal carcinoma. J Clin Oncol 1994, 12:2288\u20132295.","journal-title":"J Clin Oncol"},{"key":"32_CR17","doi-asserted-by":"publisher","first-page":"1964","DOI":"10.1002\/1097-0142(19930315)71:6<1964::AID-CNCR2820710607>3.0.CO;2-T","volume":"71","author":"N Kemeny","year":"1993","unstructured":"Kemeny N, Conti JA, Sigurdson E, et al.: A pilot study of hepatic artery floxuridine combined with systemic 5- fluorouracil and leucovorin: a potential adjuvant pro-gram after resection of colorectal hepatic metastases. Cancer 1993, 71:1964\u20131971.","journal-title":"Cancer"},{"key":"32_CR18","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1002\/1097-0142(19890715)64:2<379::AID-CNCR2820640207>3.0.CO;2-8","volume":"64","author":"F Safi","year":"1989","unstructured":"Safi F, Bittner R, Roscher R, et al.: Regional chemother-apy for hepatic metastases of colorectal carcinoma (continuous intraarterial versus continuous intraarte-rial \/ intravenous therapy). Cancer 1989, 64:379\u2013387.","journal-title":"Cancer"},{"key":"32_CR19","doi-asserted-by":"publisher","first-page":"3303","DOI":"10.1200\/JCO.2003.03.142","volume":"21","author":"N Kemeny","year":"2003","unstructured":"Kemeny N, Jarnagin W, Gonen M, et al.: Phase I\/II study of hepatic arterial therapy with floxuridine and dex-amethasone in combination with intravenous irinote-can as adjuvant treatment after resection of hepatic metastases from colorectal cancer. J Clin Oncol 2003, 21:3303\u20133309.","journal-title":"J Clin Oncol"},{"key":"32_CR20","doi-asserted-by":"crossref","first-page":"2687","DOI":"10.1200\/JCO.2001.19.10.2687","volume":"19","author":"N Kemeny","year":"2001","unstructured":"Kemeny N, Gonen M, Sullivan D, et al.: Phase I study of hepatic arterial infusion of floxuridine and dexam-ethasone with systemic irinotecan for unresectable hepatic metastases from colorectal cancer. J Clin Oncol 2001, 19:2687\u20132695.","journal-title":"J Clin Oncol"},{"key":"32_CR21","first-page":"289","volume":"22","author":"P Paty","year":"2003","unstructured":"Paty P, Fong Y, Harris R, et al.: Update of phase I studies of hepatic arterial infusion of floxuridine and dexam-ethasone pous: systemic oxaliplatin and irinotecan or systemic oxaliplatin snd fluorouracil and leucovorin for unresectable hepatic metastases from colorectal cancer. Proc Am Soc Clin Oncol 2003, 22:289.","journal-title":"Proc Am Soc Clin Oncol"},{"key":"32_CR22","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1200\/JCO.2000.18.2.243","volume":"18","author":"M Lorenz","year":"2000","unstructured":"Lorenz M, Mueller H: Randomized, multicenter trial of fluorouracil plus leucovorin administered either via hepatic arterial or intravenous infusion versus fluorode-oxyuritine administered via hepatic arterial infusion in patients with nonresectable liver metastases from col-orectal carcinoma. J Clin Oncol 2000, 18:243\u2013254.","journal-title":"J Clin Oncol"},{"key":"32_CR23","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/S0140-6736(03)12388-4","volume":"361","author":"DJ Kerr","year":"2003","unstructured":"Kerr DJ, McArdle CS, Ledermann J, et al.: Intrahepatic arterial versus intravenous fluorouracil and folinic acid for colorectal cancer liver metastases: a multicen-tre randomized trial. Lancet 2003, 361:368\u2013373.","journal-title":"Lancet"},{"key":"32_CR24","first-page":"252","volume":"22","author":"N Kemeny","year":"2003","unstructured":"Kemeny N, Niedzwiecki D, Hollis DR, et al.: Hepatic arterial infusion versus systemic therapy for hepatic metastases from colorectal cancer; a CALGB randomized trial of effi-cacy, quality of life, cost effectiveness, and molecular markers. Proc Am Soc Clin Oncol 2003, 22:252\u20130. The first randomized trial to demonstrate a statistically signif-icant improvement in survival when comparing HAI FUDR with systemic 5FU. With close monitoring and strict criteria for dose adjustments, HAI chemotherapy-associated toxicity was markedly improved when compared to earlier trials.","journal-title":"Proc Am Soc Clin Oncol"},{"key":"32_CR25","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1007\/s10434-000-0490-2","volume":"7","author":"F Meric","year":"2000","unstructured":"Meric F, Patt Y, Curley SA, et al.: Surgery after downstag-ing of unresectable hepatic tumors with intra-arterial chemotherapy. Ann Surg Oncol 2000, 7:490\u2013495.","journal-title":"Ann Surg Oncol"},{"key":"32_CR26","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1002\/1097-0142(19860201)57:3<492::AID-CNCR2820570315>3.0.CO;2-M","volume":"57","author":"MM Kemeny","year":"1986","unstructured":"Kemeny MM, Goldberg D, Beatty JD, et al.: Results of a prospective randomized trial of continuous regional chemotherapy and hepatic resection as treatment of hepatic metastases from colorectal primaries. Cancer 1986, 57:492\u2013498.","journal-title":"Cancer"},{"key":"32_CR27","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1200\/JCO.1990.8.11.1885","volume":"8","author":"LD Wagman","year":"1990","unstructured":"Wagman LD, Kemeny MM, Leong L, et al.: Prospective, ran-domized evaluation of the treatment of colorectal cancer metastatic to the liver. J Clin Oncol 1990, 8:1885\u20131893.","journal-title":"J Clin Oncol"},{"key":"32_CR28","first-page":"756","volume":"228","author":"M Lorenz","year":"2000","unstructured":"Lorenz M, Mueller H, Schramm H, et al.: Randomized, multicenter trial of surgery versus surgery followed by adjuvant arterial infusion with 5-fluorouracil and foli-nic acid for liver metastases of colorectal cancer. J Clin Oncol 2000, 228:756\u2013762.","journal-title":"J Clin Oncol"},{"key":"32_CR29","doi-asserted-by":"publisher","first-page":"2039","DOI":"10.1056\/NEJM199912303412702","volume":"341","author":"N Kemeny","year":"1999","unstructured":"Kemeny N, Huang Y, Cohen A, et al.: Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer. N Engl J Med 1999, 341:2039\u20132048. Randomized trial demonstrated a statistically significant improvement in survival when administering HAI FUDR in the adjuvant setting in addition to systemic 5FU and leucov-orin, as compared to systemic 5FU and leucovorin alone. The results suggest > 10% absolute improvement in overall survival, statistically significant at 2 years, and an improve-ment in median survival of more than 12 months, also sta-tistically significant.","journal-title":"N Engl J Med"},{"key":"32_CR30","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1200\/JCO.20.6.1499","volume":"20","author":"MM Kemeny","year":"2002","unstructured":"Kemeny MM, Adak S, Gray B, et al.: Combined-modal-ity treatment for resectable metastatic colorectal carci-noma to the liver: surgical resection of hepatic metastases in combination with continuous infusion of chemotherapy \u2014 an Intergroup study. J Clin Oncol 2002, 20:1499\u20131505.","journal-title":"J Clin Oncol"},{"key":"32_CR31","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1200\/JCO.2004.05.113","volume":"22","author":"C Tournigand","year":"2004","unstructured":"Tournigand C, Andre T, Achille E, et al.: FOLFIRI fol-lowed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study. J Clin Oncol 2004, 22:229\u2013237.","journal-title":"J Clin Oncol"},{"key":"32_CR32","first-page":"253","volume":"22","author":"A DeGramont","year":"2003","unstructured":"DeGramont A, Banzi M, Navarro M, et al.: Oxaliplatin \/ 5FU \/ leucovorin in adjuvant colon cancer: results of the international randomized mosaic trial. Proc Am Soc Clin Oncol 2003, 22:253.","journal-title":"Proc Am Soc Clin Oncol"},{"key":"32_CR33","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1177\/030089160308900406","volume":"89","author":"G Fiorentini","year":"2003","unstructured":"Fiorentini G, Rossi S, Dentico P, et al.: Irinotecan hepatic arterial infusion chemotherapy for hepatic metastases from colorectal cancer: a phase II clinical study. Tumor i 2003, 89:382\u2013384.","journal-title":"Tumor i"},{"key":"32_CR34","first-page":"291","volume":"22","author":"V Boige","year":"2003","unstructured":"Boige V, Lacombe S, De Baere T, et al.: Hepatic arterial infusion oxaliplatin combined with intravenous 5-FU and folinic acid in non respectable liver metastasis of colorectal cancer: a promising option for failures to sys-temic chemotherapy. Proc Am Soc Clin Oncol 2003, 22:291.","journal-title":"Proc Am Soc Clin Oncol"},{"issue":"9319","key":"32_CR35","doi-asserted-by":"publisher","first-page":"1734","DOI":"10.1016\/S0140-6736(02)08649-X","volume":"359","author":"JM Llovet","year":"2002","unstructured":"Llovet JM, Real MI, Montana X, et al.: Arterial embolisa-tion or chemoembolisation versus symptomatic treat-ment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial. Lancet 2002, 359(9319):1734\u20131739.","journal-title":"Lancet"},{"key":"32_CR36","doi-asserted-by":"crossref","first-page":"302","DOI":"10.7326\/0003-4819-120-4-199402150-00008","volume":"120","author":"CV Moertel","year":"1994","unstructured":"Moertel CV, Johnson CM, McKusick MA, et al.: The man-agement of patients with advanced carcinoid tumors and islet cell carcinomas. Ann Intern Med 1994, 120:302\u2013309.","journal-title":"Ann Intern Med"},{"key":"32_CR37","first-page":"65","volume":"22","author":"A Lunderquist","year":"1982","unstructured":"Lunderquist A, Ericsson M, Nobin A, Sanden G: Gel-foam powder embolization of the hepatic artery in liver metastases of carcinoid tumors. Radiologe 1982, 22:65\u201370.","journal-title":"Radiologe"},{"key":"32_CR38","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1136\/bmj.287.6397.932","volume":"287","author":"PN Maton","year":"1983","unstructured":"Maton PN, Camilleri M, Griffin G, et al.: Role of hepatic arterial embolisation in the carcinoid syndrome. BMJ 1983, 287:932\u2013935.","journal-title":"BMJ"},{"key":"32_CR39","doi-asserted-by":"crossref","first-page":"149","DOI":"10.2214\/ajr.147.1.149","volume":"147","author":"CH Carrasco","year":"1987","unstructured":"Carrasco CH, Charnsangavej C, Ajani J, et al.: The carci-noid syndrome: palliation by hepatic artery emboliza-tion. Am J Roentgenol 1987, 147:149\u2013154.","journal-title":"Am J Roentgenol"},{"key":"32_CR40","doi-asserted-by":"publisher","first-page":"2227","DOI":"10.1002\/1097-0142(19900515)65:10<2227::AID-CNCR2820651011>3.0.CO;2-C","volume":"65","author":"RG Marlink","year":"1990","unstructured":"Marlink RG, Lokich JJ, Robins JR, Clouse ME: Hepatic arterial embolization for metastatic hormone-secret-ing tumors. Cancer 1990, 65:2227\u20132232.","journal-title":"Cancer"},{"key":"32_CR41","doi-asserted-by":"publisher","first-page":"2624","DOI":"10.1002\/1097-0142(19930415)71:8<2624::AID-CNCR2820710830>3.0.CO;2-B","volume":"71","author":"P Ruszniewski","year":"1993","unstructured":"Ruszniewski P, Rougier P, Roche A, et al.: Hepatic arte-rial chemoembolization in patients with liver metastases of endocrine tumors. Cancer 1993, 71:2624\u20132630.","journal-title":"Cancer"},{"key":"32_CR42","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1148\/radiology.189.2.7692465","volume":"189","author":"E Therasse","year":"1993","unstructured":"Therasse E, Breittmayer F, Roche A, et al.: Transcatheter chemoembolization of progressive carcinoid liver metastasis. Radiology 1993, 189:541\u2013547.","journal-title":"Radiology"},{"key":"32_CR43","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1159\/000201208","volume":"55","author":"ME Clouse","year":"1994","unstructured":"Clouse ME, Perry L, Stuart K, Stokes KR: Hepatic arterial chemoembolization for metastatic neuroendocrine tumors. Digestion 1994, 55:92\u201397.","journal-title":"Digestion"},{"key":"32_CR44","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1007\/s00330-002-1558-0","volume":"13","author":"A Roche","year":"2003","unstructured":"Roche A, Girish BV, de Baere T, et al.: Trans-catheter arterial chemoembolization as first-line treatment for hepatic metastases from endocrine tumors. Eur Radiol 2003, 13:136\u2013140.","journal-title":"Eur Radiol"},{"key":"32_CR45","doi-asserted-by":"crossref","first-page":"474","DOI":"10.3109\/07357909909032856","volume":"17","author":"YH Kim","year":"1999","unstructured":"Kim YH, Ajani JA, Carrasco CH, et al.: Selective hepatic arterial chemoembolization for liver metastases in patients with carcinoid tumor or islet cell carcinoma. Cancer Invest 1999, 17:474\u2013478.","journal-title":"Cancer Invest"},{"key":"32_CR46","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1001\/jama.260.7.974","volume":"260","author":"GM Mavligit","year":"1988","unstructured":"Mavligit GM, Charnsangavej C, Carrasco CH, et al.: Regression of ocular melanoma metastatic to the liver after hepatic arterial chemoembolization with cispl-atin and polyvinyl sponge. JAMA 1988, 260:974\u2013976.","journal-title":"JAMA"},{"key":"32_CR47","doi-asserted-by":"crossref","first-page":"173","DOI":"10.3816\/CCC.2002.n.022","volume":"2","author":"HS Salman","year":"2002","unstructured":"Salman HS, Cynamon J, Jagust M, et al.: Randomized phase II trial of embolization therapy versus chemoembolization therapy in previously treated patients with colorectal carcinoma metastatic to the liver. Clin Colorectal Cancer 2002, 2:173\u2013179.","journal-title":"Clin Colorectal Cancer"},{"key":"32_CR48","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1002\/(SICI)1097-0142(19990901)86:5<775::AID-CNCR12>3.0.CO;2-M","volume":"86","author":"CG Leichmann","year":"1999","unstructured":"Leichmann CG, Jacobson JR, Modiano M, et al.: Hepatic chemoembolization combined with systemic infusion of 5-fluorouracil and bolus leucovorin for patients with metastatic colorectal carcinoma: a Southwest Oncology Group pilot trial. Cancer 1999, 86:775\u2013781.","journal-title":"Cancer"},{"key":"32_CR49","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/01.RVI.0000116190.44877.04","volume":"15","author":"MF Giroux","year":"2004","unstructured":"Giroux MF, Baum RA, Soulen MC: Chemoembolization of liver metastasis from breast carcinoma. J Vasc Interv Radiol 2004, 15:289\u2013291.","journal-title":"J Vasc Interv Radiol"}],"container-title":["Current Treatment Options in Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11864-004-0032-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11864-004-0032-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11864-004-0032-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11864-004-0032-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,15]],"date-time":"2022-05-15T13:12:57Z","timestamp":1652620377000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11864-004-0032-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,10]]},"references-count":49,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2004,10]]}},"alternative-id":["32"],"URL":"https:\/\/doi.org\/10.1007\/s11864-004-0032-4","relation":{},"ISSN":["1527-2729","1534-6277"],"issn-type":[{"value":"1527-2729","type":"print"},{"value":"1534-6277","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,10]]}}}